NAD+ vs NMN vs NR: which is best?

NAD+, NMN, and NR all aim to raise nicotinamide adenine dinucleotide levels in your body. But they are three different molecules with different molecular weights, different absorption pathways, and different price points. Understanding those differences helps you pick the right one.

All three connect back to the same goal: restoring NAD+ levels that decline 40-60% during middle age [1]. The NAD injections guide covers why that decline matters and how direct NAD+ delivery works. This page compares the three main approaches to getting NAD+ levels back up.

Quick comparison

Feature	NAD+ (direct)	NMN	NR
Full name	Nicotinamide adenine dinucleotide	Nicotinamide mononucleotide	Nicotinamide riboside
Molecular weight	663 daltons	334 daltons	255 daltons
Relationship to NAD+	Is NAD+	Direct precursor (one step away)	Precursor (two steps away)
Conversion pathway	None needed	NMN → NAD+ via NMNAT enzymes	NR → NMN → NAD+ via NRK then NMNAT
Best delivery method	Injection (IV or subcutaneous)	Oral capsule or injection	Oral capsule
Oral bioavailability	Poor (too large for efficient gut absorption)	Moderate (gut-dependent, partly via microbial conversion)	Good (absorbed via nucleoside transporters)
Clinical trial evidence	Limited (mostly IV, one heart failure RCT)	Growing (multiple RCTs in healthy adults)	Most extensive (multiple RCTs since 2018)
Monthly cost (oral)	N/A (not effective orally)	$30-80	$40-70
Monthly cost (injection)	$200-500	Limited availability	Not typically injected
FDA status	Compounded prescription	Dietary supplement (but FDA challenged status in 2022)	Dietary supplement (GRAS status)
Key human trial result	Improved LVEF in heart failure patients [2]	Increased walking distance and NAD+ levels in healthy adults [3]	Raised NAD+ ~60% in middle-aged/older adults [4]

What each molecule actually is

NAD+ (nicotinamide adenine dinucleotide) is the end product. It is the coenzyme that your cells actually use for over 500 enzymatic reactions, from energy production in mitochondria to sirtuin activation to DNA repair [1]. It is a large molecule at 663 daltons, which creates problems for oral delivery. Stomach acid and intestinal enzymes break it down before it reaches circulation.

NMN (nicotinamide mononucleotide) is the immediate precursor to NAD+. Your body converts NMN to NAD+ in a single enzymatic step using NMNAT enzymes. NMN is roughly half the size of NAD+ at 334 daltons. A key question in the field has been whether NMN can cross the gut lining intact or whether it must first be converted to NR. A 2026 Nature Metabolism study clarified this: in humans, both NMN and NR appear to work partly through gut microbial conversion to nicotinic acid, which then enters the Preiss-Handler pathway to become NAD+ [5].

NR (nicotinamide riboside) is two enzymatic steps from NAD+. The body converts NR to NMN (via NRK enzymes), then NMN to NAD+ (via NMNAT). At 255 daltons, NR is the smallest of the three and absorbs efficiently through nucleoside transporters in the gut. NR holds GRAS (Generally Recognized as Safe) status from the FDA, which is a distinction the other two lack.

Bioavailability: how much reaches your cells

This is where the three molecules diverge most.

NAD+ by injection bypasses the digestive system entirely. Subcutaneous injection creates a depot of NAD+ in tissue that diffuses into local capillaries. No gut degradation, no first-pass liver metabolism. The tradeoff is inconvenience: you need a prescription, injection supplies, and either training for self-injection or clinic visits.

NAD+ taken orally is largely a non-starter. The molecule is too large and too fragile to survive the gastrointestinal tract intact in meaningful quantities. That is why oral “NAD+ supplements” are rare and why the oral supplement market focuses on precursors instead.

NMN orally raises blood NAD+ levels reliably. The 2023 multicenter trial showed dose-dependent NAD+ increases with 300-900 mg daily over 60 days, peaking at the 600 mg dose [3]. But the absorption mechanism is more complex than originally thought. The 2026 Nature Metabolism comparison found that NMN’s NAD+-boosting effect depends partly on gut bacteria converting it to nicotinic acid. This means NMN bioavailability may vary based on individual gut microbiome composition [5].

NR orally also raises blood NAD+ effectively. The 2018 Martens trial showed approximately 60% increase in blood NAD+ with 1,000 mg NR daily for 6 weeks [4]. Like NMN, the 2026 study found that NR also works partly through microbial conversion to nicotinic acid [5]. NR enters cells through dedicated nucleoside transporters (SLC29A1/A2), which gives it a theoretical advantage in absorption consistency.

The practical takeaway: all three methods raise NAD+ levels. Injections likely deliver the most NAD+ per dose to tissue. Oral NMN and NR are roughly comparable based on the only head-to-head human comparison [5], with individual variation driven partly by gut health.

Clinical evidence compared

The strength of evidence differs meaningfully across the three molecules.

NR: the most studied precursor

NR has the longest track record in human trials. The landmark Martens et al. trial (2018) gave 24 healthy adults aged 55-79 a dose of 1,000 mg NR daily for 6 weeks. NAD+ levels rose approximately 60%, with trends toward lower blood pressure and reduced arterial stiffness [4].

More recent work has expanded on this. A 2025 double-blind crossover trial in Werner syndrome patients found that 1,000 mg NR daily for 26 weeks improved arterial stiffness, reduced skin ulcer area, and showed a trend toward preserved kidney function [6]. A separate 2025 pilot study combined NR with exercise and found reduced blood pressure in middle-aged and older adults [7]. And a 4-week open-label trial in older adults with peripheral artery disease showed improvements in vascular health and cognitive function [8].

NMN: catching up quickly

NMN has fewer published trials but has generated meaningful data since 2021.

The highest-profile result came from Yoshino et al. in Science (2021): 250 mg NMN daily for 10 weeks increased muscle insulin sensitivity in prediabetic postmenopausal women [9]. A 2023 multicenter trial randomized 80 healthy adults to 300, 600, or 900 mg NMN daily for 60 days and found dose-dependent NAD+ increases, significantly improved walking distance (P < 0.01), and stable biological age markers vs increases in placebo [3].

A 2024 systematic review and meta-analysis of 8 RCTs (342 adults, NMN 250-2,000 mg/day for 14 days to 12 weeks) found no significant effect on fasting glucose, insulin, or lipid markers [10]. This suggests NMN raises NAD+ without dramatically altering metabolic markers in already healthy people.

Direct NAD+: limited but growing

Human data on injectable or IV NAD+ is the thinnest, though the available results are noteworthy.

The strongest evidence comes from a 2026 randomized trial of 180 heart failure patients who received IV NAD+ (10 mg/day) or placebo for 7 days. The NAD+ group showed significantly improved left ventricular ejection fraction (45.44% vs 42.44%, P = 0.024) [2]. A smaller 2019 pilot study documented the NAD+ metabolome changes during a 6-hour IV infusion, confirming that IV NAD+ produces a rapid spike in blood NAD+ levels with corresponding increases in metabolites [11].

The evidence gap is clear: we have multiple RCTs for NR and NMN in healthy adults, but very few for direct NAD+ administration. This does not mean injections are less effective. It means they are less studied, partly because injectable NAD+ is a prescription product while NR and NMN are marketed as supplements.

Cost comparison

Option	Monthly cost	Annual cost	What you get
Oral NR (1,000 mg/day)	$40-70	$480-840	Capsules, self-administered
Oral NMN (600 mg/day)	$30-80	$360-960	Capsules, self-administered
NAD+ injections (SC, 200 mg, 3x/week)	$200-500	$2,400-6,000	Prescription, self-injection at home
NAD+ IV drips (500 mg, 1x/month)	$500-1,500	$6,000-18,000	Clinical setting, 2-4 hour sessions

Oral precursors are 5-10x cheaper than injections on a monthly basis. The NAD injection cost guide breaks down pricing in detail, including clinic vs telehealth differences.

The cost-per-milligram of NAD+ also varies by delivery method. Compounded NAD+ for injection typically runs $0.50-2.00 per milligram at the pharmacy level. Oral NMN runs $0.05-0.15 per milligram. But milligram-to-milligram comparison is misleading because the bioavailability differs.

Who should choose what

Start with oral NMN or NR if:

• You want the most cost-effective way to raise NAD+ levels
• You prefer the convenience of a daily capsule
• You are generally healthy and pursuing preventive longevity support
• Budget is a primary consideration

Consider NAD+ injections if:

• You want the most direct delivery method with no digestive variability
• You are already comfortable with subcutaneous injections (or willing to learn)
• You are pursuing an aggressive longevity protocol alongside other peptide therapies
• You have tried oral precursors and want a more direct approach
• You have gut absorption issues that might limit oral precursor effectiveness

IV NAD+ drips make sense if:

• You want the highest single-session dose
• You do not mind the 2-4 hour clinic commitment
• Cost is not a primary concern
• You want clinical monitoring during administration

NR specifically over NMN if:

• You want the molecule with the longest safety track record in clinical trials
• FDA GRAS status matters to you
• You want a product that has been sold commercially since 2015 with consistent quality standards

NMN specifically over NR if:

• You want the direct precursor (one enzymatic step to NAD+ vs two for NR)
• The insulin sensitivity data from the Yoshino trial is relevant to your health goals [9]
• You are comfortable with the regulatory uncertainty (FDA challenged NMN’s supplement status in 2022, though it remains available)

The regulatory question

NR and NMN exist in different regulatory categories, and this matters.

NR has GRAS status and has been sold as a dietary supplement since 2015. It is the most commercially established NAD+ precursor. ChromaDex’s Niagen brand has the most clinical trial data.

NMN faced a regulatory challenge in 2022 when the FDA asserted that NMN could not be marketed as a dietary supplement because it was under investigation as a drug. This created uncertainty, though NMN supplements remain widely available. The long-term regulatory trajectory is unclear.

NAD+ for injection is a prescription compounded product. It is not sold over the counter. It must be prepared by a licensed compounding pharmacy and prescribed by a licensed provider. For information on the legal framework, see our guide on how to get peptides prescribed.

The gut microbiome factor

The 2026 Nature Metabolism study added a new dimension to this comparison [5]. Both NR and NMN appear to work partly by being converted to nicotinic acid by gut bacteria, which then raises NAD+ through the Preiss-Handler pathway. This was not previously understood.

The implication is that the effectiveness of oral NR and NMN may depend on your gut microbiome composition. People with different bacterial populations might convert these precursors at different rates. This could explain some of the individual variability seen in clinical trials.

NAD+ injections bypass this variable entirely. The NAD+ goes directly into tissue regardless of gut health. For patients with inflammatory bowel conditions, dysbiosis, or other gut issues, this is a meaningful advantage.

Frequently asked questions

Is NMN or NR better for raising NAD+ levels?▼

The 2026 Nature Metabolism study compared NR, NMN, and nicotinamide head-to-head in 65 healthy adults. NR and NMN raised circulatory NAD+ comparably over 14 days. Neither was clearly superior to the other for this endpoint [5]. The choice between them comes down to regulatory status, cost, and personal preference.

Why are NAD+ injections so much more expensive than NMN supplements?▼

Three factors: NAD+ must be compounded under sterile pharmacy conditions, it requires a prescription and provider oversight, and the molecule itself is more expensive to produce at pharmaceutical grade. Oral NMN is manufactured as a supplement with lower regulatory requirements and no prescription needed. The NAD injection cost page breaks this down in detail.

Can I take NMN and get NAD+ injections at the same time?▼

Some patients do combine oral precursors with periodic injections. There are no known interactions, as both are supplying the same molecule through different routes. Discuss combination protocols with your prescribing provider to avoid unnecessarily high dosing.

Does NMN work without gut bacteria?▼

The 2026 Nature Metabolism study suggests that gut microbial conversion to nicotinic acid is part of how NMN raises systemic NAD+ [5]. This does not mean NMN is useless without gut bacteria, but gut health likely affects how well oral NMN works for you. This is one reason some patients prefer NAD injections, which bypass the gut entirely.

Is NR safer than NMN?▼

Both have strong safety profiles in clinical trials. NR has more published long-term safety data because it has been studied since 2016. The Martens trial [4], the Werner syndrome trial [6], and several other RCTs have reported no serious adverse effects with NR at doses up to 1,000 mg/day for 26 weeks. NMN trials also report good tolerability at 250-900 mg/day for up to 12 weeks [3, 10]. Neither has demonstrated concerning safety signals.

What about nicotinamide (vitamin B3)?▼

The 2026 comparison study also included nicotinamide (Nam). Interestingly, Nam did not raise steady-state NAD+ levels the way NR and NMN did, though it did cause acute, transient changes in the blood NAD+ metabolome [5]. Nicotinamide is cheaper than both NR and NMN but appears less effective as a chronic NAD+ booster.

Which is best for anti-aging specifically?▼

For anti-aging, the molecular form matters less than consistently maintaining elevated NAD+ levels over time. Both NR and NMN achieve this orally. NAD+ injections achieve it more directly. The NAD+ for anti-aging guide covers the sirtuin activation, DNA repair, and mitochondrial benefits in detail. The best choice is the one you will use consistently over months and years.

Can I switch from NR to NMN or vice versa?▼

Yes. Both are converted to NAD+ through overlapping pathways. There is no washout period needed. Some patients switch based on cost, availability, or the evolving research base.

Ready to find out which NAD+ approach fits your health goals? Start your consultation at glp.purepeptideclinic.com to discuss options with a licensed provider.

References

1. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021;22(2):119-141. https://pubmed.ncbi.nlm.nih.gov/33353981/

2. Yu X, Xu J, Cao J, et al. Effect of nicotinamide adenine dinucleotide on heart failure caused by ischemic cardiomyopathy: a randomized, placebo-controlled trial. American Journal of Cardiovascular Drugs. 2026;26(1):97-106. https://pubmed.ncbi.nlm.nih.gov/40954388/

3. Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29-43. https://pubmed.ncbi.nlm.nih.gov/36482258/

4. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018;9(1):1286. https://pubmed.ncbi.nlm.nih.gov/29599478/

5. Christen S, Redeuil K, Goulet L, et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nature Metabolism. 2026;8(1):62-73. https://pubmed.ncbi.nlm.nih.gov/41540253/

6. Shoji M, Kato H, Koshizaka M, et al. Nicotinamide riboside supplementation benefits in patients with Werner syndrome: a double-blind randomized crossover placebo-controlled trial. Aging Cell. 2025;24(8):e70093. https://pubmed.ncbi.nlm.nih.gov/40459998/

7. Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial. GeroScience. 2025;47(6). https://pubmed.ncbi.nlm.nih.gov/40770531/

8. Effects of NAD+ supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease. The Journal of Pharmacology and Experimental Therapeutics. 2025. https://pubmed.ncbi.nlm.nih.gov/40479886/

9. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. https://pubmed.ncbi.nlm.nih.gov/33888596/

10. Chen F, Zhou D, Kong AP, et al. Effects of nicotinamide mononucleotide on glucose and lipid metabolism in adults: a systematic review and meta-analysis of randomised controlled trials. Current Diabetes Reports. 2024;25(1):4. https://pubmed.ncbi.nlm.nih.gov/39531138/

11. Grant R, Berg J, Mestayer R, et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Frontiers in Aging Neuroscience. 2019;11:257. https://pubmed.ncbi.nlm.nih.gov/31572171/